An open-label, multiple ascending dose study of the anti-CTLA-4 antibody ipilimumab in viremic HIV patients

Title
An open-label, multiple ascending dose study of the anti-CTLA-4 antibody ipilimumab in viremic HIV patients
Authors
Keywords
HIV-1, T cells, Diarrhea, Immune response, Face, HIV, Adjustment of dosage at steady state, Cytotoxic T cells
Journal
PLoS One
Volume 13, Issue 6, Pages e0198158
Publisher
Public Library of Science (PLoS)
Online
2018-06-08
DOI
10.1371/journal.pone.0198158

Ask authors/readers for more resources

Reprint

Contact the author

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started